Search

Home > Annals On Call Podcast > Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Podcast: Annals On Call Podcast
Episode:

Semaglutide Versus Dulaglutide or Empagliflozin: Death and Cardiovascular Outcomes for Patients With Type 2 Diabetes
Category: Science & Medicine
Duration: 00:29:55
Publish Date: 2025-08-18 21:00:00
Description: Dr. Centor discusses outcomes in patients with type 2 diabetes when treated with semaglutide or dulaglutide versus empagliflozin with Drs. Kevin Kip and Anum Saeed.
Total Play: 0